Cumberland Pharmaceuticals Stock Performance
| CPIX Stock | USD 3.86 0.11 2.93% |
Cumberland Pharmaceuticals holds a performance score of 13 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.44, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cumberland Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cumberland Pharmaceuticals is expected to be smaller as well. Use Cumberland Pharmaceuticals treynor ratio, as well as the relationship between the expected short fall and day median price , to analyze future returns on Cumberland Pharmaceuticals.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain forward indicators, Cumberland Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 18.3 M | |
| Total Cashflows From Investing Activities | 57.8 K |
Cumberland | Build AI portfolio with Cumberland Stock |
Cumberland Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 233.00 in Cumberland Pharmaceuticals on November 5, 2025 and sell it today you would earn a total of 153.00 from holding Cumberland Pharmaceuticals or generate 65.67% return on investment over 90 days. Cumberland Pharmaceuticals is currently generating 1.0045% in daily expected returns and assumes 6.0831% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Cumberland, and 80% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cumberland Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Cumberland Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.86 | 90 days | 3.86 | about 30.69 |
Based on a normal probability distribution, the odds of Cumberland Pharmaceuticals to move above the current price in 90 days from now is about 30.69 (This Cumberland Pharmaceuticals probability density function shows the probability of Cumberland Stock to fall within a particular range of prices over 90 days) .
Cumberland Pharmaceuticals Price Density |
| Price |
Predictive Modules for Cumberland Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cumberland Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cumberland Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cumberland Pharmaceuticals is not an exception. The market had few large corrections towards the Cumberland Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cumberland Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cumberland Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.98 | |
β | Beta against Dow Jones | 0.44 | |
σ | Overall volatility | 1.09 | |
Ir | Information ratio | 0.16 |
Cumberland Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cumberland Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cumberland Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cumberland Pharmaceuticals is way too risky over 90 days horizon | |
| Cumberland Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 37.87 M. Net Loss for the year was (6.48 M) with profit before overhead, payroll, taxes, and interest of 34.88 M. | |
| Cumberland Pharmaceuticals currently holds about 18.22 M in cash with (612.19 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24. | |
| Roughly 42.0% of the company shares are held by company insiders |
Cumberland Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cumberland Stock often depends not only on the future outlook of the current and potential Cumberland Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cumberland Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.1 M | |
| Cash And Short Term Investments | 18 M |
Cumberland Pharmaceuticals Fundamentals Growth
Cumberland Stock prices reflect investors' perceptions of the future prospects and financial health of Cumberland Pharmaceuticals, and Cumberland Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cumberland Stock performance.
| Return On Equity | -0.13 | |||
| Return On Asset | -0.0286 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 50.38 M | |||
| Shares Outstanding | 14.96 M | |||
| Price To Earning | (16.05) X | |||
| Price To Book | 2.15 X | |||
| Price To Sales | 1.40 X | |||
| Revenue | 37.87 M | |||
| EBITDA | 182.42 K | |||
| Cash And Equivalents | 18.22 M | |||
| Cash Per Share | 1.24 X | |||
| Total Debt | 20.57 M | |||
| Debt To Equity | 0.50 % | |||
| Book Value Per Share | 1.75 X | |||
| Cash Flow From Operations | (612.19 K) | |||
| Earnings Per Share | (0.24) X | |||
| Total Asset | 75.58 M | |||
| Retained Earnings | (23.97 M) | |||
| Current Asset | 66.96 M | |||
| Current Liabilities | 11.69 M | |||
About Cumberland Pharmaceuticals Performance
Evaluating Cumberland Pharmaceuticals' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Cumberland Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cumberland Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. Cumberland Pharmaceu operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.Things to note about Cumberland Pharmaceuticals performance evaluation
Checking the ongoing alerts about Cumberland Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cumberland Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cumberland Pharmaceuticals is way too risky over 90 days horizon | |
| Cumberland Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 37.87 M. Net Loss for the year was (6.48 M) with profit before overhead, payroll, taxes, and interest of 34.88 M. | |
| Cumberland Pharmaceuticals currently holds about 18.22 M in cash with (612.19 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24. | |
| Roughly 42.0% of the company shares are held by company insiders |
- Analyzing Cumberland Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cumberland Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Cumberland Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cumberland Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cumberland Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cumberland Pharmaceuticals' stock. These opinions can provide insight into Cumberland Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.